Navigation Links
University of Tennessee professor receives Gates Foundation Award to reinvent condom, improve global health
Date:11/20/2013

Condoms have the power to make the world healthier by preventing disease and unplanned pregnancies, yet they are vastly underutilized.

This year, Bill and Melinda Gates and their foundation issued a challenge to develop the next generation of condoms. Called Grand Challenges in Global Health, the initiative aims to foster scientific and technological innovation to solve key health problems in the developing world.

Jimmy Mays, a chemistry professor at the University of Tennessee, Knoxville, responded to the challenge with a design that will encourage condom use in developing countries. He has received $100,000 from the Bill and Melinda Gates Foundation for research and development of a prototype.

"Jimmy's work is exceptional and exemplary of how the research done in the labs here at UT has the potential to catalyze change throughout the world," said Chancellor Jimmy G. Cheek. "This award enables him to find more solutions to problems that have a dramatic effect on our lives."

According to the challenge, condoms have a stigma that they decrease pleasure. The challenge is to reinvent the condom so that it significantly preserves or enhances pleasure in order to increase regular use.

Mays' innovative condom design incorporates his work with superelastomerspolymers that can be repeatedly stretched further than existing rubbers without permanently deforming the shape of the material. These improved properties will allow condoms to be made thinner, enhancing the user experience. In addition, the use of superelastomers will allow the condoms to be made by a less expensive injection molding process that should lower cost, allow for texturing of the condom surface, and enable softness and texture of skin.

Today, more than 33 million people around the world are living with HIV and the number of newly infected people each year outnumbers those who gain access to treatment by two to one, according to the foundation. Mays' invention will be part of a comprehensive response to stop the pandemic.

"This product could lead to substantial benefits for global health, both in terms of reducing the incidence of unplanned pregnancies and in prevention of infection with HIV or other sexually transmitted infections," said Mays.

The superelastomers were discovered through a long-term collaboration between Mays, Roland Weidisch of Fraunhofer Institute in Germany and Samuel Gido of the University of Massachussetts, Amherst.

"We continue to push for a regular stream of fresh ideas to help overcome persistent health and development challenges," said Chris Wilson, director of global health discovery and translational sciences at the Bill and Melinda Gates Foundation. "Innovative thinking fuels the progress needed to overcome obstacles the world faces to pull people out of poverty."


'/>"/>

Contact: Whitney Heins
wheins@utk.edu
865-974-5460
University of Tennessee at Knoxville
Source:Eurekalert  

Related medicine news :

1. Cybex and Auburn University Celebrates First Semester of Fitness
2. Georgetown University 50-State Report Finds More Children Have Health Coverage - Attributes Gains to Successful Federal State Partnership Programs Medicaid and CHIP
3. Midmark Corporation Makes Donation to The Ohio State University College of Medicine to Foster Efficient, Effective Patient Care
4. University of Massachusetts Medical School Opens New Center for FSHD Research and Training
5. $2.8 million for Concordia University research
6. Tel Aviv University part of team launching global Human Brain Project
7. Washington University and Barnes-Jewish Heart Specialists Hold CME Event: Top Advancements in the Treatment of Structural Heart Disease
8. Western University of Health Sciences’ Gala Fundraiser Emphasizes Humanism and Caring
9. Animal, human health benefits anticipated from universitys premier biomedical instrument
10. Website Solutions Company Announces Website for Health Equity Research at Texas A&M University
11. New Poll Shows CalUniversity and Other Accredited Online Colleges Best Value for Education
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
University of Tennessee professor receives Gates Foundation Award to reinvent condom, improve global health
(Date:6/27/2016)... ... June 27, 2016 , ... ... to revolutionize the emergency ambulance transport experience for the millions of people who ... Uber has disrupted the taxi industry through the use of technology. Now, SmartEMS ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: